Osteosarcopenia is a musculoskeletal disorder characterised by the simultaneous impairment
of bone and muscle tissue. The canonical Wnt/β-catenin signalling pathway (cWnt) may play
an important role in its development, although the expression of its regulators in bone tissue
remains poorly understood. This study aimed to assess the expression of SOST, DKK1,
SFRP1 and WNT10B in bone tissue from women with osteosarcopenia (OSA) and
osteoporosis without sarcopenia (OP).
Gene expression was analysed using real-time quantitative polymerase chain reaction
(qPCR) in bone tissue obtained during hip replacement surgery. Based on the skeletal muscle
mass index (ASM/height²), patients were classified into OSA (n = 17) and OP (n = 26)
groups. Associations with clinical and biochemical parameters were also investigated. The
results were complemented by direct molecular counting in 48 bone tissue samples and
bioinformatic analysis of transcriptomic data from six mesenchymal stem cell (MSC)
samples using Ingenuity Pathway Analysis (IPA).
The qPCR conditions were optimised for SOST, DKK1 and SFRP1, whereas WNT10B was
excluded due to inadequate amplification specificity and efficiency. No statistically
significant differences in gene expression were observed between the groups using qPCR or
direct molecular counting, with consistent findings for SFRP1. Transcriptomic analysis of
MSCs showed lower SOST and higher SFRP1 expression in the sarcopenic group, but neither
difference remained significant after correction for multiple testing. IPA highlighted
potential molecular relationships between SOST and NKD2 or JPH2, and between SFRP1
and ACTA2. A significant association was identified between higher serum free
triiodothyronine concentrations and higher SOST expression in bone tissue (Spearman's r =
−0.457; adjusted p-value = 0.0092).
Sarcopenia was not associated with significant differences in the expression of the
investigated genes in the osteoporotic cohort. The association between free triiodothyronine
and SOST expression, together with the bioinformatically identified relationships, provides
a basis for further investigation of osteosarcopenia mechanisms and potential diagnostic and
therapeutic targets.
|